Can methylene blue improve brain health?
Short Answer: Methylene blue enhances mitochondrial function by acting as an alternative electron carrier in the electron transport chain. Preclinical data shows neuroprotective effects, and it's being studied for Alzheimer's (as LMTM/TRx0237).
Evidence Level: preliminary
Detailed Answer
Methylene blue (MB) is a century-old drug with unique mitochondrial properties: it can accept electrons from NADH and transfer them directly to cytochrome c, effectively bypassing Complex I and III deficiencies. This 'electron shuttle' function makes it relevant to neurodegeneration where mitochondrial dysfunction is central. At low doses (0.5-2mg/kg), MB improves mitochondrial respiration, reduces reactive oxygen species, and inhibits tau protein aggregation. TRx0237 (LMTM), a methylthioninium derivative, showed positive signals in an Alzheimer's Phase III trial as monotherapy but not as add-on to cholinesterase inhibitors. MB also enhances memory consolidation in rodent studies (Gonzalez-Lima lab, UT Austin) through improved brain metabolic rate. Safety: USP-grade MB is well-tolerated; industrial-grade contains contaminants. Serotonin syndrome risk if combined with SSRIs.
Sources
- Atamna H et al. (2008) FASEB J
- Gauthier S et al. (2016) Lancet — LMTM trial